use of neratinib in her2-positive breast cancer
Published 6 years ago • 1.5K plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:39
dr. anders discusses the use of neratinib/capecitabine for her2-positive brain metastases
-
9:35
neratinib in her2 breast cancer
-
4:09
her2 breast cancer: neratinib patient selection
-
8:33
pending fda approval of neratinib in her2 breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
3:15
neratinib for metastatic breast cancer
-
1:08
dr. isaacs discusses the role of neratinib in her2 breast cancer
-
1:40
dr. tolaney discusses neratinib in her2 breast cancer
-
1:57
dr. dietrich on adverse event management for neratinib in breast cancer
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer
-
1:20
dr. tripathy discusses neratinib in her2 breast cancer
-
8:12
her2 breast cancer: neratinib’s role as adjuvant therapy
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer
-
1:41
dr. traina discusses neratinib in her2 breast cancer
-
1:07
dr. mitri on neratinib and pertuzumab in her2-amplified breast cancer
-
0:25
copy of dr. shao on managing toxicity with neratinib in her2 breast cancer